Clinical Significance of Central Obesity in Laparoscopic Bariatric Surgery

Wei Jei Lee, Weu Wang, Tai Chi Chen, Po Li Wei, Ching Mei Lin, Ming Te Huang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Laparoscopic surgery had increased the interest and growth of bariatric surgery. Whether central obesity has any adverse effect in laparoscopic bariatric surgery is not clear. Methods: 612 morbidly obese patients received laparoscopic bariatric surgery, in a prospectively controlled clinical trial of the outcome of the bariatric surgery. For comparison, subjects were dichotomized into either a central obesity group or peripheral obesity group, based on waist/hip ratio (WHR). Various biochemistry and blood count variables, and perioperative and postoperative results were measured. Results: There were more female (458) than male patients (154). Male patients had higher BMI, and female patients were younger. 56 of 154 male patients (36.4%) belonged to the central obesity (WHR >1.0), and 321 of 458 female patients (70.1%) had central obesity (WHR >0.85). Central obesity was associated with age but not with BMI in males. In females, central obesity was associated with increased BMI. Central obesity predicted increased hyperglycemia and triglyceride levels in both male and female patients. Male patients with central obesity had higher WBC counts than the other patients. Although central obesity was associated with more infra-operative blood loss and prolonged recovery in female patients, there was no increase in complication rate or difference in postoperative weight loss. Conclusion: Central obesity Is associated with a higher degree of hyperglycemia, hyperlipidemia and leukocytosis In morbidly obese patients who undergo bariatric surgery. Although there is increased technical difficulty in patients with severe central obesity, laparoscopic bariatric surgery is safe and effective in producing weight loss.

Original languageEnglish
Pages (from-to)921-925
Number of pages5
JournalObesity Surgery
Volume13
Issue number6
DOIs
Publication statusPublished - Dec 2003
Externally publishedYes

Fingerprint

Bariatric Surgery
Abdominal Obesity
Laparoscopy
Waist-Hip Ratio
Hyperglycemia
Weight Loss
Morbid Obesity
Leukocytosis
Controlled Clinical Trials
Hyperlipidemias
Biochemistry
Triglycerides
Obesity

Keywords

  • Bariatric surgery
  • Central obesity
  • Laparoscopy
  • Morbid obesity

ASJC Scopus subject areas

  • Surgery

Cite this

Clinical Significance of Central Obesity in Laparoscopic Bariatric Surgery. / Lee, Wei Jei; Wang, Weu; Chen, Tai Chi; Wei, Po Li; Lin, Ching Mei; Huang, Ming Te.

In: Obesity Surgery, Vol. 13, No. 6, 12.2003, p. 921-925.

Research output: Contribution to journalArticle

Lee, Wei Jei ; Wang, Weu ; Chen, Tai Chi ; Wei, Po Li ; Lin, Ching Mei ; Huang, Ming Te. / Clinical Significance of Central Obesity in Laparoscopic Bariatric Surgery. In: Obesity Surgery. 2003 ; Vol. 13, No. 6. pp. 921-925.
@article{3f68383fae5f440fad822e63bfa36713,
title = "Clinical Significance of Central Obesity in Laparoscopic Bariatric Surgery",
abstract = "Background: Laparoscopic surgery had increased the interest and growth of bariatric surgery. Whether central obesity has any adverse effect in laparoscopic bariatric surgery is not clear. Methods: 612 morbidly obese patients received laparoscopic bariatric surgery, in a prospectively controlled clinical trial of the outcome of the bariatric surgery. For comparison, subjects were dichotomized into either a central obesity group or peripheral obesity group, based on waist/hip ratio (WHR). Various biochemistry and blood count variables, and perioperative and postoperative results were measured. Results: There were more female (458) than male patients (154). Male patients had higher BMI, and female patients were younger. 56 of 154 male patients (36.4{\%}) belonged to the central obesity (WHR >1.0), and 321 of 458 female patients (70.1{\%}) had central obesity (WHR >0.85). Central obesity was associated with age but not with BMI in males. In females, central obesity was associated with increased BMI. Central obesity predicted increased hyperglycemia and triglyceride levels in both male and female patients. Male patients with central obesity had higher WBC counts than the other patients. Although central obesity was associated with more infra-operative blood loss and prolonged recovery in female patients, there was no increase in complication rate or difference in postoperative weight loss. Conclusion: Central obesity Is associated with a higher degree of hyperglycemia, hyperlipidemia and leukocytosis In morbidly obese patients who undergo bariatric surgery. Although there is increased technical difficulty in patients with severe central obesity, laparoscopic bariatric surgery is safe and effective in producing weight loss.",
keywords = "Bariatric surgery, Central obesity, Laparoscopy, Morbid obesity",
author = "Lee, {Wei Jei} and Weu Wang and Chen, {Tai Chi} and Wei, {Po Li} and Lin, {Ching Mei} and Huang, {Ming Te}",
year = "2003",
month = "12",
doi = "10.1381/096089203322618786",
language = "English",
volume = "13",
pages = "921--925",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York LLC",
number = "6",

}

TY - JOUR

T1 - Clinical Significance of Central Obesity in Laparoscopic Bariatric Surgery

AU - Lee, Wei Jei

AU - Wang, Weu

AU - Chen, Tai Chi

AU - Wei, Po Li

AU - Lin, Ching Mei

AU - Huang, Ming Te

PY - 2003/12

Y1 - 2003/12

N2 - Background: Laparoscopic surgery had increased the interest and growth of bariatric surgery. Whether central obesity has any adverse effect in laparoscopic bariatric surgery is not clear. Methods: 612 morbidly obese patients received laparoscopic bariatric surgery, in a prospectively controlled clinical trial of the outcome of the bariatric surgery. For comparison, subjects were dichotomized into either a central obesity group or peripheral obesity group, based on waist/hip ratio (WHR). Various biochemistry and blood count variables, and perioperative and postoperative results were measured. Results: There were more female (458) than male patients (154). Male patients had higher BMI, and female patients were younger. 56 of 154 male patients (36.4%) belonged to the central obesity (WHR >1.0), and 321 of 458 female patients (70.1%) had central obesity (WHR >0.85). Central obesity was associated with age but not with BMI in males. In females, central obesity was associated with increased BMI. Central obesity predicted increased hyperglycemia and triglyceride levels in both male and female patients. Male patients with central obesity had higher WBC counts than the other patients. Although central obesity was associated with more infra-operative blood loss and prolonged recovery in female patients, there was no increase in complication rate or difference in postoperative weight loss. Conclusion: Central obesity Is associated with a higher degree of hyperglycemia, hyperlipidemia and leukocytosis In morbidly obese patients who undergo bariatric surgery. Although there is increased technical difficulty in patients with severe central obesity, laparoscopic bariatric surgery is safe and effective in producing weight loss.

AB - Background: Laparoscopic surgery had increased the interest and growth of bariatric surgery. Whether central obesity has any adverse effect in laparoscopic bariatric surgery is not clear. Methods: 612 morbidly obese patients received laparoscopic bariatric surgery, in a prospectively controlled clinical trial of the outcome of the bariatric surgery. For comparison, subjects were dichotomized into either a central obesity group or peripheral obesity group, based on waist/hip ratio (WHR). Various biochemistry and blood count variables, and perioperative and postoperative results were measured. Results: There were more female (458) than male patients (154). Male patients had higher BMI, and female patients were younger. 56 of 154 male patients (36.4%) belonged to the central obesity (WHR >1.0), and 321 of 458 female patients (70.1%) had central obesity (WHR >0.85). Central obesity was associated with age but not with BMI in males. In females, central obesity was associated with increased BMI. Central obesity predicted increased hyperglycemia and triglyceride levels in both male and female patients. Male patients with central obesity had higher WBC counts than the other patients. Although central obesity was associated with more infra-operative blood loss and prolonged recovery in female patients, there was no increase in complication rate or difference in postoperative weight loss. Conclusion: Central obesity Is associated with a higher degree of hyperglycemia, hyperlipidemia and leukocytosis In morbidly obese patients who undergo bariatric surgery. Although there is increased technical difficulty in patients with severe central obesity, laparoscopic bariatric surgery is safe and effective in producing weight loss.

KW - Bariatric surgery

KW - Central obesity

KW - Laparoscopy

KW - Morbid obesity

UR - http://www.scopus.com/inward/record.url?scp=0346887075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346887075&partnerID=8YFLogxK

U2 - 10.1381/096089203322618786

DO - 10.1381/096089203322618786

M3 - Article

C2 - 14738683

AN - SCOPUS:0346887075

VL - 13

SP - 921

EP - 925

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 6

ER -